drugset / Trial / NCT02798159
Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to identify the optimal dose(s) of TD0025 for treatment of erectile dysfunction (phase II) and to investigate if treatment of erectile dysfunction with the optimal dose of TD0025 taken as needed over one month is non-inferior than Sildenafil Citrate taken as needed over one month (phase III)
Timeline
- Start
- 2016-05
- Primary completion
- 2018-03-01
- Completion
- 2018-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sildenafil | Unknown | 50 mg | Oral |
| Subject | TD0025 | Unknown | — | Oral |